Journal article · Vestibular← The news desk

✦ The Dispatch

Long-term outcomes of LINAC single-dose versus fractionated stereotactic radiation for vestibular schwannoma

A dispatch from PubMed — filed

Vestibular schwannomas (VS) are increasingly being managed with LINAC-based stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (fSRT). There is a paucity of long-term outcomes especially in relation to post-treatment volumetric tumour and pseudoprogression data.

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

This retrospective comparison may inform radiation oncology planning for vestibular schwannoma, but audiologists should await prospective data before changing referral or counseling practices.

✦ Why It Matters ✦

Understanding which radiation approach better preserves hearing and controls tumor growth could directly shape multidisciplinary management guidelines for vestibular schwannoma.

✦ Key Points ✦
  1. 01Retrospective design comparing single-dose LINAC radiosurgery vs. fractionated stereotactic radiotherapy for vestibular schwannoma.
  2. 02Long-term outcomes assessed — likely including tumor control, hearing preservation, and cranial nerve function.
  3. 03Vestibular schwannomas are a key differential in audiology practice requiring specialist referral.
  4. 04Findings could influence referral pathways and patient counseling about radiation options.
  5. 05Retrospective methodology limits causal inference; prospective trials are needed.
✦ Claims & Evidence ✦

Long-term outcomes differ between single-dose LINAC radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.

studypartially supported
✦ Research metadata ✦
PMID
43059592
DOI
10.1080/02688697.2026.2764164.
Journal
British Journal of Neurosurgery
Publication type
research_article
Evidence level
4
Population
Patients with vestibular schwannoma treated with stereotactic radiation
Intervention
Single-dose LINAC stereotactic radiosurgery
Comparator
Fractionated stereotactic radiotherapy

Primary outcomes

Tumor control rate; Hearing preservation; Cranial nerve outcomes

✦ Related stories ✦